Yahoo Finance

GLP-1 Agonists Drug Pipeline Analysis Market Report 2025 | Next-generation GLP-1 Agonists Pave the Way for Diabetes and Obesity Management

Dublin, July 14, 2025 (GLOBE NEWSWIRE) -- The "GLP-1 Agonists Drug Pipeline Analysis Report 2025" drug pipelines has been added to ResearchAndMarkets.com's offering. The GLP-1 Agonists Drug Pipeline ...
Yahoo Finance

Huntington’s Disease Clinical Trial Pipeline Analysis: 20+ Key Companies Shaping the Future of Dopamine Receptor Antagonists Therapeutics | DelveInsight

New York, USA, June 03, 2025 (GLOBE NEWSWIRE) -- Huntington’s Disease Clinical Trial Pipeline Analysis: 20+ Key Companies Shaping the Future of Dopamine Receptor Antagonists Therapeutics | ...
The Globe and Mail

Parainfluenza Virus Infection Pipeline Analysis and Clinical Trials Assessment, 2025 by DelveInsight | AlloVir, Ansun Biopharma, Moderna Therapeutics

DelveInsight’s, "Parainfluenza Virus Infection - Pipeline Insight, 2025,” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Parainfluenza Virus Infection pipeline ...
Yahoo Finance

Pneumococcal Infections Clinical Trial Analysis: Key Insights into Rich Pipeline Featuring 15+ Companies and 20+ Therapies | DelveInsight

New York, USA, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Pneumococcal Infections Clinical Trial Analysis: Key Insights into Rich Pipeline Featuring 15+ Companies and 20+ Therapies | DelveInsight The ...
The Globe and Mail

Meibomian gland dysfunction Pipeline Analysis & Clinical Trials, 2025, DelveInsight | Azura Ophthalmics, Santen Pharmaceutical

"DelveInsight’s, “Meibomian Gland Dysfunction- Pipeline Insight, 2025” report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in Meibomian Gland Dysfunction pipeline landscape ...
Investing

BridgeBio Pharma’s SWOT analysis: stock shows promise amid pipeline progress

BridgeBio Pharma, Inc. (NASDAQ:BBIO), a pharmaceutical company focused on developing treatments for genetic diseases and cancers with clear genetic drivers, has been making significant strides in its ...